Stereotactic Radiosurgery Outcomes in Uveal Melanoma Patients: A 3-year Retrospective Study
Authors:
Jozef Sklenka 1,2; Pavla Horňáčková 1,2; Daniela Vysloužilová 1,2; Veronika Matušková 1,2; Jan Němčanský 3; Radoslava Uhmannová 1; Moussa Goutaib 1; Oldřich Chrapek 1,2
Authors‘ workplace:
Eye Clinic, University Hospital, Brno, Czech republic
1; Department of Ophthalmology, Faculty of Medicine, Masaryk University, Brno, Czech Republic
2; Department of Ophthalmology, University Hospital Ostrava, Czech Republic
3
Published in:
Čes. a slov. Oftal., 82, 2026, No. 4, p. 196-203
Category:
Original Article
doi:
https://doi.org/10.31348/2025/48
Overview
Aim: To evaluate the three-year survival rate, local tumor control rate and complications of stereotactic radiosurgery in patients with uveal melanoma and compare the outcomes with the available literature.
Material and Methods: In this study, data were evaluated from 122 patients treated for uveal melanoma, of whom 33 met the inclusion criteria for retrospective analysis of stereotactic radiosurgery outcomes using the CyberKnife system. These patients received radiotherapy for uveal melanoma during the period of 2016–2021. The data were collected during regular follow-up visits consisting of best-corrected visual acuity assessment, slit-lamp examination, indirect ophthalmoscopy, intraocular pressure measurement and ultrasound measurement of tumor prominence. As part of the metastases screening, abdominal ultrasound, chest X-ray, and magnetic resonance imaging (MRI) of the brain and orbits were performed regularly, with additional positron emission tomography (PET) combined with MRI performed as required.
Results: In our cohort, the three-year eye preservation rate was 72.7%, while the three-year local tumor control reached the level of 75.8%. The three-year survival was 81.8%. Overall, metastases were detected in 30.3% of patients with the liver being affected in 44% of cases, the bones in 28%, and the lungs in 17%. The most common ocular complications of radiotherapy included cataracts (58.3% of phakic patients), neovascular glaucoma (39.4%), radiation maculopathy (27.3%) and radiation retinopathy (18.2%).
Conclusion: Stereotactic radiosurgery is a safe treatment method for uveal melanoma with the potential for eye preservation. However, it carries the risk of tumor recurrence and ocular complications. Three-year survival and the incidence of ocular complications in our study were consistent with the data reported in the literature. By contrast, three-year local tumor control reached lower values compared to the relevant studies. Some results may be limited due to the small number of subjects in our cohort.
Keywords:
Radiosurgery – uveal melanoma – cyberknife – radiation retinopathy – neovascular glaucoma
Sources
1. Collaborative Ocular Melanoma Study Group. The Collaborative Ocular Melanoma Study (COMS) randomized trial of pre-enucleation radiation of large choroidal melanoma: IV. Ten-year mortality findings and prognostic factors. COMS report number 24. Am J Ophthalmol. 2004 Dec;138(6):936-951.
2. Collaborative Ocular Melanoma Study Group. The COMS Randomized Trial of Iodine 125 Brachytherapy for Choroidal Melanoma: V. Twelve-Year Mortality Rates and Prognostic Factors: COMS Report No. 28. Arch Ophthalmol. 2006 Dec;124(12):1684.
3. Rusňák Š, Hecová L, Kasl Z, Sobotová M, Hauer L. Therapy of Uveal Melanoma. A Review. Cesk Slov Oftalmol. 2021 Aug;77(1):1-13. doi: 10.31348/2020/X10
4. De Salles AAF, Gorgulho AA, Pereira JLB, McLaughlin N. Intracranial Stereotactic Radiosurgery. Neurosurg Clin N Am. 2013 Oct;24(4):491-498.
5. Eibl-Lindner K, Fürweger C, Nentwich M, et al. Robotic radiosurgery for the treatment of medium and large uveal melanoma. Melanoma Res. 2016 Feb;26(1):51-57.
6. Klingenstein A, Fürweger C, Nentwich MM, et al. Quality of life in the follow-up of uveal melanoma patients after CyberKnife treatment. Melanoma Res. 2013 Dec;23(6):481-488.
7. Groenewald C, Konstantinidis L, Damato B. Effects of radiotherapy on uveal melanomas and adjacent tissues. Eye. 2013 Feb;27(2):163 - 171.
8. Yazici G, Kiratli H, Ozyigit G, et al. Every other day stereotactic radiation therapy for the treatment of uveal melanoma decreases toxicity. Radiother Oncol. 2022 Nov;176 : 39-45.
9. Mueller A. Stereotactic radiosurgery of large uveal melanomas with the gamma-knife. Ophthalmology. 2000 July;107(7):1381 - 1387.
10. Šimonová G, Novotný J, Liščák R, Pilbauer J. Leksell gamma knife treatment of uveal melanoma. J Neurosurg. 2002 Dec;97 : 635-639.
11. Dunavoelgyi R, Dieckmann K, Gleiss A, et al. Local Tumor Control, Visual Acuity, and Survival After Hypofractionated Stereotactic Photon Radiotherapy of Choroidal Melanoma in 212 Patients Treated Between 1997 and 2007. Int J Radiat Oncol. 2011 Sept;81(1):199-205.
12. Schmelter V, Schneider F, Guenther SR, et al. Local Recurrence in Choroidal Melanomas following Robotic-Assisted Radiosurgery (CyberKnife). Ocul Oncol Pathol. 2022;8(4–6):221-229.
13. Krohn J, Froystein T, Dahl O. Posterior uveal melanoma. Distribution of the sites of origin and patterns of tumour extent in the ocular fundus. British Journal of Ophthalmology. June 2008;92(6):751–756.
14. Collaborative Ocular Melanoma Study Group. Incidence of Cataract and Outcomes after Cataract Surgery in the First 5 Years after Iodine 125 Brachytherapy in the Collaborative Ocular Melanoma Study. Ophthalmology. 2007 July;114(7):1363-1371.e4.
15. Zehetmayer M, Kitz K, Menapace R, et al. Local tumor control and morbidity after one to three fractions of stereotactic external beam irradiation for uveal melanoma. Radiother Oncol. 2000 May;55(2):135-144.
16. Modorati GM, Dagan R, Mikkelsen LH, Andreasen S, Ferlito A, Bandello F. Gamma Knife Radiosurgery for Uveal Melanoma: A Retrospective Review of Clinical Complications in a Tertiary Referral Center. Ocul Oncol Pathol. 2020;6(2):115-122.
17. Krema H, Somani S, Sahgal A, et al. Stereotactic radiotherapy for treatment of juxtapapillary choroidal melanoma: 3-year follow-up. Br J Ophthalmol. 2009 Sept;93(9):1172-1176.
18. Sarici AM, Pazarli H. Gamma-knife-based stereotactic radiosurgery for medium - and large-sized posterior uveal melanoma. Graefes Arch Clin Exp Ophthalmol. 2013 Jan;251(1):285-294.
19. Wackernagel W, Holl E, Tarmann L, et al. Local tumour control and eye preservation after gamma-knife radiosurgery of choroidal melanomas. Br J Ophthalmol. 2014 Feb;98(2):218-223.
20. Suesskind D, Scheiderbauer J, Buchgeister M, et al. Retrospective Evaluation of Patients With Uveal Melanoma Treated by Stereotactic Radiosurgery With and Without Tumor Resection. JAMA Ophthalmol. 2013 May;131(5):630.
21. Dinca EB, Yianni J, Rowe J, et al. Survival and complications following Gamma Knife radiosurgery or enucleation for ocular melanoma: a 20-year experience. Acta Neurochir (Wien). 2012 Apr;154(4):605-610.
22. Matuskova V, Hornackova P, Uhmannova R, et al. Uveal melanoma - testing of abnormalities of chromosome 3 and 8 in the Czech Republic. Biomed Pap. 2020 Dec;164(4):401-409.
23. Chan AW, Lin H, Yacoub I, Chhabra AM, Choi JI, Simone CB. Proton Therapy in Uveal Melanoma. Cancers. 2024 Oct;16(20):3497.
24. Mor JM, Semrau R, Baus W, et al. CyberKnife®: Eine neue Therapieoption bei uvealem Melanom. Ophthalmol. 2018 Apr;115(4):302 - 308.
25. Van Beek JGM, Van Rij CM, Baart SJ, et al. Fractionated stereotactic radiotherapy for uveal melanoma: Long‐term outcome and control rates. Acta Ophthalmol (Copenh). 2022 Aug;100(5):511-519.
26. Stålhammar G, Herrspiegel C. Long-term relative survival in uveal melanoma: a systematic review and meta-analysis. Commun Med. 2022 Mar;2(1):18.
Labels
OphthalmologyArticle was published in
Czech and Slovak Ophthalmology
2026 Issue 4
Most read in this issue
- Role slzného filmu v refrakci: Kvantitativní hodnocení před a po terapii na přístroji Rexon-Eye
- Refrakční lensektomie u pacientů s Fuchsovou endotelovou dystrofií
- Effect of the ACE inhibitor Zofenopril on the Oxidative Status of the Eye in Animals with Experimental Glaucoma
- Exudative Retinal Detachment in Preeclampsia. Case Reports